Isolation And Characterisation Of Chemical Constituents With Anti-Methicilin Resistant Staphylococcus Aureus Activity From Mesua Ferrea Leaf Extract by Alagasamy, Sangeeta Vani
  
 
ISOLATION AND CHARACTERISATION OF 
CHEMICAL CONSTITUENTS WITH ANTI-
METHICILIN RESISTANT STAPHYLOCOCCUS 
AUREUS ACTIVITY FROM MESUA FERREA 
LEAF EXTRACT 
 
 
 
 
SANGEETA VANI ALAGASAMY 
 
 
 
 
UNIVERSITI SAINS MALAYSIA  
2018
  
ISOLATION AND CHARACTERISATION OF 
CHEMICAL CONSTITUENTS WITH ANTI-
METHICILIN RESISTANT STAPHYLOCOCCUS 
AUREUS ACTIVITY FROM MESUA FERREA 
LEAF EXTRACT 
 
 
by 
  
 
SANGEETA VANI ALAGASAMY 
 
 
Thesis submitted in fulfilment of the requirements  
for the degree of  
Master of Science 
 
May 2018
    
ii 
ACKNOWLEDGEMENT 
 
 First and foremost, I would like to humbly offer this dissertation as an 
offering of love to the lotus feet of Their Lordships Sri Sri Radha Krishna Kanhaiya, 
Sri Sri Nitai Gauranga Rai and Srila Prabhupada. Without Their causeless mercy, I 
would not have able to finish this project. As Lord Krishna has stated in Chapter 9 
text 27 of the holy Bhagavad Gita: 
yat karosi yad asnasi    yaj juhosi dadasi yat 
yat tapasyasi kaunteya      tat kurusva mad-arpanam 
“O son of Kunti, all that you do, all that you eat, all that you offer and give away, 
as well as all austerities that you may perform, should be done as an offering 
unto Me.” My utmost gratitude goes to my spiritual master (diksa guru), HH 
Jayapataka Swami Guru Maharaj for always showing me sheer determination and 
love in serving Srila Prabhupada and his mission. By following his great example, I 
can only humbly pray to his lotus feet to make me a tool in the service of Srila 
Prabhupada’s movement in the future. As the famous poet Narottama das Thakur 
says, “The lotus feet of the spiritual master are the abode of pure devotional service. I 
bow down to those lotus feet with great care and attention.” 
 I would like to convey my deepest gratitude to my supervisor and siksa guru, 
Prof. Dr. Surash Ramanathan @ HG Surabala das for allowing me a place to learn 
and grow under him. Without his patience in paving the way for me, I would not 
have completed this thesis. He has provided professional and spiritual guidance for 
me throughout these years and for that I can’t thank him enough. I would like to 
thank my co-supervisors Dr. Lai Choon Sheen and Assoc. Prof. Dr. Vickneswaran 
    
iii 
Murugaiyah for guiding and teaching me throughout this project. I am truly indebted 
to them for always lending me a helping hand during hard times. 
 A special thanks to my godsisters Dr. Yasodha Ponnusamy @ HG Yasodha 
Yasomathi dd and Dr. Suhanya Partasarathy @ HG Sulochana Radhika dd for their 
encouragement and invaluable advises. I would like to thank Center for Drug 
Research for giving me the opportunity to pursue my graduate studies and all the 
supporting staff and colleagues who have created a cheerful and happy environment 
for me. Special thanks to Mr.Asokan, Mr.Arunacalam, and Mr.Hilman for assisting 
me to operate the analytical instruments. 
 Last but not least, I would like to take this opportunity to thank my one and 
only family for all the sacrifices that they have made for me. My father HG Adharma 
Satru das, my mother HG Rupavathi Sundari dd and my siblings, HG Dr.Simharaj 
Narahari das, HG Srivasudha Subasini dd and HG Vrajasri Radha dd who have been 
very supportive towards my mental, emotional and spiritual being all these years. 
Without their prayers and moral support, I would not have able to finish this project. 
 Finally, one has to understand that the ultimate knowledge is to attain the 
Supreme Personality of Godhead as Lord Krishna says to Arjuna in the Bhagavad 
Gita, Chapter 10 Text 32: 
sarganam adir antas ca      madhyam caivaham arjuna 
adhyatma-vidya vidyanam      vadah pravadatam aham 
“Of all creations I am the beginning and the end and also the middle, O Arjuna. 
Of all sciences I am the spiritual science of the Self, and among logicians I am 
the conclusive truth!” Hare Krishna! 
    
iv 
TABLE OF CONTENTS 
 
 
ACKNOWLEDGMENT                                                                                          ii 
TABLE OF CONTENTS                                                                                          iv 
LIST OF TABLES                                                                                                   viii 
LIST OF FIGURES                                                                                                    x 
LIST OF SYMBOLS AND ABBREVIATIONS                                                   xiii 
ABSTRAK                                                                                                                xix 
ABSTRACT                                                                                                              xxi 
CHAPTER 1  BACKGROUND 1 
CHAPTER 2 LITERATURE REVIEW 4 
2.1 Staphylococcus aureus 4 
2.1.1 S. aureus infections 5 
2.1.2 Prevalence of S. aureus resistance 6 
2.2   Methicillin resistant Staphylococcus aureus (MRSA) 7 
2.2.1 Strategies to fight MRSA 7 
2.2.2 Ethnomedical Remedies against MRSA 9 
2.3 Mesua ferrea Linn. 10 
2.3.1 Botanic Description 10 
2.3.2 Biology and Ecology 12 
2.3.3 Distribution 12 
2.3.4 Uses 12 
    
v 
2.3.5 Ethnopharmacological relevance of Mesua ferrea Linn 13 
2.3.6 Pharmacological Activities 14 
 Disinfection studies 14 
 Antioxidant and hepatoprotective activity 14 
 Analgesic activity 15 
 Antispasmodic activity 15 
 Anti-venom activity 16 
 Anti-ulcer activity 16 
 Anti-microbial activity 16 
2.3.7 Phyto-constituents 18 
2.4 Herbal mixtures versus isolated compounds 21 
2.5 Separation techniques 22 
2.6 Compound identification and structure elucidation 25 
2.7 Antibacterial activity 27 
2.7.1 Microdilution assay 27 
2.7.2 Minimum Inhibitory Concentration (MIC) 27 
2.7.3 Minimum Bactericidal Concentration (MBC) 27 
CHAPTER 3 MATERIALS AND METHOD 29 
3.1 Chemicals & Materials 29 
3.2 Equipment and Instrumentation 30 
3.3 Plant material 30 
3.4 Preparation of plant material and optimization of extraction method 31 
3.4.1 Drying method 31 
3.4.2 Particle size 32 
    
vi 
3.4.3 Solid to solvent ratio 33 
3.4.4 Extraction technique 34 
3.5 Enrichment of M. ferrea leaf methanolic extract 35 
3.5.1 Liquid-liquid extraction (solvent partitioning) of M. ferrea 
methanolic leaf extract 35 
3.5.2 Chromatography of extract using dry vacuum liquid 
chromatography 37 
3.6 Isolation of compounds 38 
3.6.1 First fractionation 38 
3.6.2 Second fractionation 39 
3.6.3 Isolation of biactive compounds 40 
3.6.4 Compound identification and structure elucidation 41 
 Gas Chromatography-Mass spectrometry (GC-MS) 41 
 Nuclear Magnetic Resonance (NMR) 41 
3.6.5 Steroidtesting 41 
 Salkowski test 41 
 Liebermann-Burchard test 41 
3.7 In vitro antibacterial assay 42 
3.7.1 Bacteria culture and preparation 42 
3.7.2 Broth micro dilution assay 42 
3.7.3 Determination of Minimum Bactericidal Concentration (MBC) 44 
3.7.4 Synergistic interaction between active compound with antibiotic 44 
CHAPTER 4 RESULTS AND DISCUSSION 47 
4.1 Optimization of extraction conditions of Mesua ferrea leaves 48 
    
vii 
4.1.1 Drying method 49 
4.1.2 Particle size 50 
4.1.3 Solid to solvent ratio 52 
4.1.4 Extraction technique 53 
4.2 Enrichment of M. ferrea leaf methanolic extract 56 
4.2.1 Liquid-liquid extraction of M. ferrea methanolic leaf extract 56 
4.2.2 Fractionation 59 
4.3 Isolation of compounds 64 
4.3.1 Compound 1 64 
4.3.2 Compound 2 81 
4.4 Determination of Minimum Inhibitory Concentration (MIC)                   
and Minimum Bactericidal Concentration (MBC) 101 
4.5 Synergistic interaction between stigmasterol and caryophyllene oxide with 
antibiotics 103 
CHAPTER 5  CONCLUSION 109 
REFERENCES 110 
APPENDICES                   127 
  
 
 
 
 
 
    
viii 
LIST OF TABLES 
 
 
Table 3.1 List of chemicals and reagents 29 
 
Table 3.2 Equipment and Instrumentation 30 
 
Table 3.3 Solvent gradient for dry vacuum liquid 
chromatography of bioactive extract. 38 
 
Table 3.4 Mobile phase for sub-fractions of F3 39 
 
Table 3.5 Mobile phase for sub-fractions of S4 40 
 
Table 4.1 Bioassay guided study of M. ferrea leaf 
extracts after subjected to various drying 
methods. 49 
 
Table 4.2 Bioassay guided study of freeze dried M. 
ferrea leaf extract after the plant leaves were 
grounded to various particle sizes. 51 
 
Table 4.3 Bioassay guided study of freeze dried M. 
ferrea leaf (particle size 0.5mm) after 
subjected to extraction by various solid to 
solvent ratio 52 
 
Table 4.4 Bioassay guided study of freeze dried M. 
ferrea leaf [particle size 0.5mm; solid to 
solvent ratio 1:15(w/v)], after maceration or 
ultra-sonication in methanol.   53 
 
Table 4.5 Minimum inhibitory concentration of the 
fractions of MeOH extracts (µg/mL). 58 
 
Table 4.6 Minimum inhibitory concentration of the 
fractions of n-Hexane extracts (µg/mL). 60 
 
Table 4.7 Minimum inhibitory concentration of the sub-
fractions of F3 (µg/mL). 62 
 
Table 4.8 Minimum inhibitory concentration of the sub-
fractions of S4 (µg/mL). 63 
 
Table 4.9 Minimum inhibitory concentration of the 
compounds 1, 2, 3 and 4 (µg/mL). 64 
 
Table 4.10 FTIR values of compound 1. 66 
Page 
    
ix 
Table 4.11 Comparison of assignments of both 1H NMR 
and 13C NMR data with literature review 76 
 
Table 4.12 1H NMR of compound 2. 84 
 
Table 4.13 HSQC coupling data summary table for 
compound 2. 86 
 
Table 4.14 13C NMR chemical shift of compound 2 94 
 
Table 4.15 Key COSY correlations. 99 
 
Table 4.16 Minimum Inhibitory Concentration (MIC) and 
Minimum Bactericidal Concentration (MBC) 
of stigmasterol and caryophyllene oxide 
(µg/mL).  
 
Table 4.17 The MIC value of antibiotics alone, 
stigmasterol alone, in combination and their 
respective FICI values against S.aureus and 
MRSA 107                                                        
 
Table 4.18 The MIC value of antibiotics alone, 
Caryophyllene oxide alone, in combination 
and their respective FICI values against 
S.aureus and MRSA. 108 
 
Table 7.1 Ingredients of Brahma Rasayana 127 
 
Table 7.2 Percentage of yield for drying method 131 
 
Table 7.3 Percentage of yield for particle size 131 
 
Table 7.4 Percentage of yield for solvent ratio 132 
 
Table 7.5 Percentage of yield for extraction technique 132 
 
 
 
 
 
 
 
 
 
 
 
102 
    
x 
LIST OF FIGURES 
 
 
 
Figure 2.1 Mesua ferrea tree in Universiti Sains 
Malaysia. 11 
 
Figure 2.2 Mesua ferrea Linn. – A. Small branch with a 
flower (x1); B. L.s through a flower showing 
floral parts (x2); C. Part of a filament with 
anther; D. T.s through ovary; E. A small fruit; 
F. Bursting fruit (x1/2). 11 
 
Figure 2.3 Chemical structures of compounds isolated 
from M. ferrea 19 
 
Figure 3.1 Flow chart for the selection of the most 
effective drying method for Mesua ferrea  
leaves using   antibacterial guided assay 32 
 
Figure 3.2 Flow chart for the selection of the optimal 
particle size of the powdered Mesua ferrea 
leaves using antibacterial guided assay 33 
 
Figure 3.3 Flow chart for the selection of the optimal 
solid to solvent (ratio) extraction condition for 
Mesua ferrea powdered leaves using 
antibacterial guided assay. 34 
 
Figure 3.4 Flow chart of comparison of two extraction 
technique of Mesua ferrea powdered leaves 
using antibacterial guided assay. 35 
 
Figure 3.5 Flow chart for the liquid-liquid extraction 
(partitioning) from the methanol sample. 37 
 
Figure 3.6 Layout of 96-well microtiter plate for 
microdilution assay 43 
 
Figure 3.7 Schematic diagram for the determination of 
Minimum Bactericidal Concentration (MBC). 44 
 
Figure 3.8 Schematic flow chart of the bioassay guided 
compound isolation structural elucidation and 
synergistic testing.                46 
 
Figure 4.1 The summary of the optimization of the 
extraction procedure of Mesua ferrea leaves. 55 
Page 
    
xi 
Figure 4.2 Structure of isolated compound 1. 65 
 
Figure 4.3 FTIR spectrum (in KBr pellet) of compound1. 67 
 
Figure 4.4 (a) GC-MS of compound 1; (b) GC-MS 
reference of stigmasterol from NIST 
Chemistry WebBook. 68 
 
Figure 4.5 1H NMR spectrum of compound 1 (CD3OD, 
500MHz). 71 
 
Figure 4.6 13C NMR spectrum of compound 1 (CD3OD, 
125MHz) 80 
 
Figure 4.7 13C DEPT-90 NMR spectrum of compound 1 
(CD3OD, 125MHz) 78 
 
Figure 4.8 13C DEPT-135 NMR spectrum of compound 1 
(CD3OD, 125MHz) 79 
 
Figure 4.9 HSQC spectrum of compound 1 (CD3OD, 
500MHz) with key correlations. 78 
 
Figure 4.10 HMBC spectrum of compound 1 (CD3OD, 
500MHz) with key correlations. 79 
 
Figure 4.11 COSY spectrum of compound 1 (CD3OD, 
125MHz) 80 
 
Figure 4.12 Chemical structure of compound 2. 81 
 
Figure 4.13 (a) GC-MS of compound 2; (b) GC-MS 
reference of caryophyllene oxide from NIST 
Chemistry WebBook. 82 
 
Figure 4.14 1H spectrum of compound 2 (CD3OD, 
500MHz) 85 
 
Figure 4.15 13C spectrum of compound 2 
(CD3OD,125MHz) 88 
 
Figure 4.16 13C DEPT-90 NMR spectrum of compound 2 
in CDCl3 89 
 
Figure 4.17 13C DEPT-135 NMR spectrum of compound 2 
in CDCl3 90 
 
Figure 4.18 HSQC spectrum of compound 2 (CDCl3, 
500MHz) 91 
    
xii 
Figure 4.19 HMBC spectrum of compound 2 (CDCl3, 
500MHz) 92 
 
Figure 4.20 Expansion of HMBC spectrum of compound2 93 
 
Figure 4.21 Logical assembly of structure of Fragment 1 
to 4 based on HMBC data. 95 
 
Figure 4.22 Logical assembly of structure of Fragment 4 
to 5a and 5b based on HMBC data. 96 
 
Figure 4.23 Logical assembly of structure of Fragment 5a 
to 7 based on HMBC data. 96 
 
Figure 4.24 Logical assembly of structure of Fragment 7 
and 8 to 9a and 9b based on HMBC data. 97 
 
Figure 4.25 Logical assembly of structure of Fragment 9b 
to the structure 10 based on HMBC data. 98 
 
Figure 4.26 COSY spectrum of compound 2 (CDCl3, 
125MHz) 100 
 
Figure 7.1 TLC profile for fraction F3 132 
 
Figure 7.2 TLC profile for sub-fraction S4 133 
 
Figure 7.3 TLC profile for sub-fraction T8 133 
 
 
 
 
 
 
 
 
 
 
 
    
xiii 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
% Percentage 
°C Degree Celcius 
Α Alpha  
Β Beta 
µ Micro  
µg/mL Microgram per milliliter 
µL Microliter 
ALT Alanine aminotransferase 
AMX Amoxicillin 
APCI Atmospheric-pressure chemical ionization 
AR Analytical  grade 
AST Aspartate aminotransferase 
ATCC American type culture collection 
B. subtilis Bacilllus  subtilis 
CAT Catalase 
CFU Colony forming unit 
    
xiv 
CHCl3 Chloroform  
CI Chemical ionization 
cm Centimeter 
CO2 Carbon dioxide 
COSY Homonuclear correlation spectroscopy 
CPK Creatinine phosphorkinase 
DMSO Dimethyl sulfoxide 
dd Doublet of doublet 
DEPT Distortionless enhancement by population 
transfer 
E. coli Escherichia coli 
EI Electron impact ionization   
ESI Electrospray ionization 
EtOAc Ethyl Acetate 
F3 Fraction F3 
FAB Fast atom bombardment 
FDA Food and drug administration, United states 
FICI Fractional inhibitory concentration indices 
FT Fourier Transform 
    
xv 
g Gram 
GC-MS Gas chromatography-mass spectrometry 
GPX Glutathione peroxidase 
GR Glutathione reductase 
H2O Water 
H2O2 Hydrogen peroxide 
HMBC Heteronuclear Multiple Bond Coherence 
hr Hour 
HSQC Heteronuclear Single Bond Coherence 
HTS High throughput screening 
Hz Hertz 
IC50 Concentration of a test substance required for 
50 % inhibition in vitro 
INT para iodonitrotetrazolium 
IR Infrared Radiation 
J Coupling constant 
KBr Potassium Bromide 
khz Kilohertz 
L Liter 
    
xvi 
LC-MS Liquid chromatography-mass spectrometry 
m Meter 
m Multiplet 
MALDI Matrix-assisted laser desorption/ionization 
MBC Minimum bactericidal concentration 
M. ferrea Mesua ferrea 
MeOH Methanol 
mg/kg Milligram per kilogram 
mg/mL Milligrams per milliliter 
MHA Mueller Hinton agar 
MHB Mueller Hinton broth 
MIC Minimum inhibitory concentration 
min Minute 
mL Milliliter 
mL/min Milliliter per minute 
mm Millimeter 
MRSA Methicillin-resistant Staphylococcus aureus 
MS Mass spectrometry 
    
xvii 
MSSA Methicillin-sensitive Staphylococcus aureus 
n-BuOH n-Buthanol 
NMR Nuclear magnetic resonance 
P. aeruginosa Pseudomonas aeruginosa 
ppm Parts per million 
prep-TLC Preparative thin layer chromatography 
Rf Retention factor 
Rpm Revolution per minute 
s Singlet 
S4 Sub-fraction S4 
S. aureus Staphylococcus aureus 
SCCmec Staphylococcal cassette chromosome, mec 
SFD Staphylococcal foodborne diseases 
SOD Super oxide dismutase 
t Triplet 
T8 Sub-fraction T8 
TLC Thin layer chromatography 
TMS Tetramethylsilane 
    
xviii 
 
 
 
 
 
 
 
 
 
 
 
 
 
UV Ultraviolet 
v/v Volume over volume 
WHO World Health Organization 
w/v Weight over volume 
    
xix 
PEMENCILAN DAN PENCIRIAN SEBATIAN DENGAN AKTIVITI ANTI-
METHICILIN TAHAN STAPHYLOCOCCUS AUREUS DARI EKSTRAK 
DAUN MESUA FERREA 
 
ABSTRAK 
Tujuan kajian ini adalah untuk mengasingkan kompaun yang mempunyai 
aktiviti antimikrobial dari daun Mesua ferrea (M. ferrea) dengan menggunakan 
pendekatan berpandukan bioesei. Memandangkan ini, satu prosedur pengekstrakan 
dan pemencilan sebatian berasaskan bioesei antimikrobial telah dijalankan ke atas 
ekstrak metanolik daun M. ferrea dengan bakteria Gram positif dan negatif. Bagi 
permulaan, teknik pengekstrakan daun M. ferrea dioptimumkan dengan kaedah 
berpandukan esei antimikrobial. Serbuk beku kering daun M. ferrea (saiz partikel 0.5 
mm) dalam methanol (1:15 w/v) dengan bantuan ekstraksi ultrasonik dapat 
menghasilkan ekstrak mentah dengan aktiviti antibakteria yang baik terhadap S. 
aureus, MRSA, P. aeruginosa, B. subtilis dan E. coli. Ekstrak mentah metanol, 
seterusnya dipartisikan dengan pelbagai pelarut untuk mendapatkan pecahan aktif 
daun M. ferrea. Fraksi (T8) menunjukkan aktiviti antibakteria yang paling kuat 
terhadap S. aureus dan MRSA dan terus tertakluk kepada pemencilan berpandu esei 
antibakteria. Empat sebatian telah diasingkan di mana stigmasterol dan 
caryophyllene oksida menunjukkan aktiviti antibakteria yang baik terhadap S. aureus 
dan MRSA dengan nilai MIC 31.25, 62.5 μg/mL dan 15.625, 31.25 μg/mL masing-
masing. Nilai MBC > 500 µg/mL mencadangkan bahawa kedua-dua stigmasterol dan 
caryophyllene oksida adalah sebatian bakteriostatik. Baki dua kompaun mempuyai 
nilai MIC melebihi 500 µg/mL. Kedua-dua sebatian ini tidak dipertimbangkan untuk 
    
xx 
penentuan struktur. Aktiviti antibakteria stigmasterol dan caryophellene oksida 
adalah jauh lebih baik apabila diberikan dalam kombinasi dengan antibiotik daripada 
digunakan sebagai sebatian tunggal. Kedua-dua sebatian ini didapati menunjukkan 
kesan sinergi dengan antibiotik konvensional, penisilin G, ampicillin dan 
chloramphenicol terhadap S. aureus dan MRSA. Interaksi sinergistik menunjukkan 
bahawa aktiviti antibakteria antibiotik telah dipertingkatkan dan gabungan produk 
semulajadi dengan agen antibakteria ini boleh digunakan sebagai ubat terhadap 
bakteria yang rintangan terhadap pelbagai ubat. Sebagai kesimpulan, kajian ini 
pertama kali melaporkan kaedah pengekstrakan dan pemencilan sebatian dari ekstrak 
metanolik daun M. ferrea berpandukan esei antibakteria. Sinergi antara bioaktiviti 
daun M. ferrea (stigmasterol dan caryophyllene oksida) dan antibiotik konvensional 
terhadap S. aureus dan MRSA juga pertama kali ditunjukkan. Fakta yang menarik 
ialah, stigmasterol diasingkan daripada daun M. ferrea buat pertama kali. Kajian ini 
juga mengesahkan kehadiran caryophyllene oksida dalam daun M. ferrea melalui 
kajian NMR.  
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ISOLATION AND CHARACTERISATION OF CHEMICAL 
CONSTITUENTS WITH ANTI-METHICILIN RESISTANT 
STAPHYLOCOCCUS AUREUS ACTIVITY FROM MESUA FERREA LEAF 
EXTRACT 
 
ABSTRACT 
The present study aims to isolate compounds with antimicrobial activity   
from Mesua ferrea leaf employing bioassay guided approach.  An antibacterial assay 
guided extraction and compound isolation procedure was carried out on Mesua 
ferrea methanolic leaf extract with a number of Gram positives and negatives 
bacteria.  Firstly, M. ferrea leaf extraction technique was optimized using 
antimicrobial assay guided method.  Powdered freeze dried leaves of M. ferrea 
(particle size 0.5mm)  (1:15w/v)    using ultrasonic-assisted technique  yielded 
methanol crude  extract with   a good antibacterial  activity against Staphylococcus 
aureus, MRSA,  Pseudomonas aeruginosa, Bacillus subtilis and Escherichia coli.   
The methanolic crude extract was further partitioned with various solvents to obtain 
active fractions of M. ferrea leaf. Sub-fraction (T8) demonstrated the strongest 
antibacterial activity against S. aureus and MRSA and was further subjected to 
antibacterial assay guided isolation.  Four compounds were isolated of which 
stigmasterol and caryophyllene oxide  demonstrated good antibacterial activity 
against S. aureus and MRSA with MIC values of   31.25, 62.5 µg/mL and 15.625, 
31.25 µg/mL respectively. The MBC values of > 500 µg/mL suggested that both 
stigmasterol and caryophyllene oxide are bacteriostatic compounds. As for the 
remaining two compounds the MIC values were    above 500 µg/mL. These 
    
xxii 
compounds were not considered for structural elucidation. The antibacterial activity 
of stigmasterol and caryophyllene oxides was far better when given in combination 
with antibiotics than used as a single compound. Both compounds were found to 
show synergism with conventional antibiotics, ampicillin, chloramphenicol, and 
penicillin G against S. aurues and MRSA.  The synergistic interactions indicated that 
the antibacterial activities of antibiotics were improved and combining natural 
products with these antibacterial agents could be useful against infectious multi-drug 
resistant bacteria. In conclusion, this study first reported the bioassay guided 
extraction and isolation of bioactives from M. ferrea methanolic leaf extract.  The 
synergism between the M. ferrea leaf bioactives (stigmasterol and caryophyllene 
oxide) and the conventional antibiotics against S. aureus and MRSA were also first 
demonstrated. Interestingly, stigmasterol was first isolated from the leaves of Mesua 
ferrea. This study also confirmed the presence of caryophyllene oxide in the leaves 
of M. ferrea by NMR assignment. 
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CHAPTER 1 
BACKGROUND 
 
Infectious diseases have become the leading source of death world-wide. The 
emergence of new multidrug-resistant pathogens is threatening the many existing 
antibiotics clinical effectiveness (Bandow et al., 2003). Scientific articles describing 
the prevalence of resistance of S. aureus against the conventional antibiotics, 
reported approximately 90–95% of the isolated S. aureus was penicillin resistant 
while 70–80% of the same microorganism was methicillin resistant (Casal et al., 
2005; Chambers, 2001).Hence, antibiotic resistance has become an interest globally 
(Wesch et al., 2004). In addition, the increasing failure of chemotherapeutics and the 
toxicity of the allopathy drugs had prompted researchers to look for an alternative 
therapy. (Iwu et al., 1999).  
 
Natural product research appear to be a promising option for exploring new 
compounds with antimicrobial activity. These new compounds with varied chemical 
structures and unique action mechanisms provides a bright platform to fight the 
current and recurring infectious diseases (Rojas et al., 2003). Natural products can 
cater boundless opportunities either as standardized herbal extracts or as pure 
isolated compounds, for new drug establishment because of the immeasurable 
availability of chemical diversity. As a result of this, folk medicine has been 
increasingly examined, in pursuit for new drug leads to develop a better treatment 
against microbial diseases (Tambekar et al., 2010; Benkeblia, 2004). 
Natural product research does not only emphasis on finding new leads, but 
also focus on the effort to revamp regular antibiotics with better efficiency. Several 
2 
researches have disclosed unique findings such as the synergistic effects of 
standardized plant extracts when used together with regular antibiotics. For example 
pomegranate extract, pyridine and myricetin that were isolated from Jatropha 
elliptica, displayed compelling synergistic effect when employed together with 
regular antibiotics such as gentamicin, oxacillin, tetracycline, chloramphenicol, and 
ampicillin (Braga et al., 2005; Lin et al., 2005). Synergy studies have been testified 
to be a good alternative strategy to development of new antibacterial agent as the 
latter has been proven to be expensive and time consuming. Development of 
resistance towards regular antibiotics are somewhat easy being that these antibiotics 
have been largely of microbial roots and therefore susceptible to random mutation. 
Unlike to these regular antibiotics, natural products have a more diverse and novel 
structures that are not of typical to microbes (Cowan, 1999). Therefore, there has 
been an upsurge of recent studies that focuses on the synergistic effect of plant 
extracts or compounds with regular antibiotics in order to lessen the future prospects 
of developing antibiotic-resistant bacterial strains. Besides perpetuating the potent 
lifespan of an antibiotic, this can also scale down the side effects that are caused by 
these antibiotics. 
 
In Malaysia, the traditional practitioners use medicinal plants and plant juices 
to treat illness and this practice is still in use (Samuel et al., 2010). Since there is a 
high demand on herbal drugs and traditional plants that have antibacterial activity, 
study and research are enormously taking place. One of those local medicinal plants 
of interest is Mesua ferrea Linn.  Past studies have shown M. ferrea Linn bark, seed 
and flowers extracts to have antibacterial properties against a number of Gram 
positives and negatives bacteria (Ali et al., 2004 and Prashanth et al., 2006). 
3 
Aruldass et al. (2013) reported antibacterial activity of M. ferrea methanolic leaf 
extract against S. aureus. A similar study was carried out by Adewale et al. (2012) 
against a spectrum of bacteria using M. ferrea leaf methanolic and ethanolic extracts 
and found antibacterial activities. Ali et al. (2004) tested the chloroform, petroleum 
and ethanolic extracts of M. ferrea leaf against various bacteria and reported 
promising antimicrobial activities.  
However most of the previous studies reported on M. ferrea were conducted 
on the crude extracts instead of its active fraction or compounds.  Studies to further 
isolate the bioactives responsible for the antibacterial properties are lacking. Hence, 
in recognition of its antibacterial properties, the current study was undertaken to 
examine the antibacterial activity of M. ferrea leaf extracts, fractions and sub 
fractions.  After then, a systemic bioassay guided isolation of compounds from M. 
ferrea leaf extract was carried out.  Finally, the synergism between the conventional 
antibiotics and the isolated bioactives of M. ferrea leaf extract were   determined.   
 With this in view and present work focussed on the following objectives : 
1. To optimize the extraction method for M. ferrea leaf by bioassay 
guided   method with antibacterial activity. 
2. To isolate, characterize and elucidate the structure of the  bioactives 
or compounds that are  responsible for the antibacterial activities 
found in the active fractions of M. ferrea leaf. 
3. To evaluate the antibacterial activity and any synergistic effect of the 
isolated compounds with regular antibiotics. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive, round-shaped bacterium relatively 
1 μm in diameter. Being widely known as “golden staph” due to its formation of 
golden colonies, the cells are often found on skins, and noses. Cell division usually 
takes place in more than one plane, S. aureus commonly appears as a grape-like 
clusters. (Crossley & Archer, 1997). Approximately 20–30% of the general 
population has been estimated to be carriers of S. aureus (Heyman, 2004). Colonies 
of S. aureus on sheep blood agar plates, often cause β-hemolysis (Ryan & Ray, 
2004). In order to protect the pathogen, the presence of careotenoids has been 
disclosed to be a virulence factor against oxidants produced by the immune system 
and its presence is also the cause for the golden pigmentation of S. aureus colonies 
(Liu et al., 2005). Staphyloccoci are capable to yield lactic acid by fermentation, 
besides generating energy by aerobic respiration. 
Staphylococcus sp. is catalase-positive as they are able to produce the enzyme 
catalase, a trait discerning them from Streptococcus sp. They are also oxidase-
negative and requirement of complex nutrients, e.g., vitamins B and many amino 
acids, is much needed for growth. S. aureus has a very high tolerance for sodium 
chloride, as it is able to tolerate concentration up to 1.7 molar. Besides this, another 
prominent trait of this genus is the peptidoglycan structure of the cell wall which 
contains multiple glycine residues in the crossbridge. This trait is that which causes 
susceptibility to lysostaphin (Crossley & Archer, 1997). S. aureus produces 
coagulase that enables the conversion of fibrinogen into fibrin. This conversion is 
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done when coagulase interacts with prothrombin in the blood resulting in plasma to 
coagulate. Most of the members of the genus are generally entitled as coagulase-
negative staphylococci, so blood coagulation is therefore a trait used to differentiate 
S. aureus from the others. (Ryan & Ray, 2004). Due to being a common ethological 
agent of human ailments and the ability to exhibit resistance to an increasing amount 
of healing agents, S. aureus is therefore one of the most extensively investigated 
bacterial strains. 
 
2.1.1 S. aureus infections 
S. aureus is a commensal bacteria and a pathogen. The mucosal surfaces and 
skin are the main sites of colonization. Approximately 20–30% of humans are 
tenacious carriers of S. aureus, and 30% are intermittent carriers. The stubborn 
carriers are always colonized by this bacteria strain while the intermittent ones are 
colonized transiently (Wertheim et al., 2005). When host defence is compromised, 
colonization provides a source of the pathogen from which bacteria are brought in 
and thus significantly increasing the possibility of infections (Kluytmans et al., 
1997). S. aureus infected patients are normally affected by the same commensal 
strain that they carry (Williams et al., 1959).  
Diekema et al. (2001) reported that S. aureus is an important source for 
hospital- and community-acquired infections that may develop severe problem. 
Nosocomial S. aureus infections can badly influence the skin, bloodstream, lower 
respiratory tracts and soft tissues. Besides causing serious deep rooted infections like 
osteomyelitis and endocarditis, it can also be the reason for ventilator-assisted 
pneumonia and central venous catheter-associated bacteremia (Schito, 2006). Not 
only that, S. aureus is also usually responsible for diseases that are toxin-mediated, 
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like staphylococcal foodborne diseases (SFD), scalded skin syndrome and toxic 
shock syndrome. Due to their constant catheter insertions and injections and their 
compromised immune system, patients in the hospitals are normally the ones that are 
notably prone to S. aureus infections (Lindsay & Holden, 2004). During a two- year 
period of survey, the SENTRY Surveillance Program that investigated worldwide S. 
aureus infections reported that this pathogen is the leading cause for skin or soft 
tissues, lower respiratory tract and bloodstream infections in all the regions that were 
studied (Diekema et al., 2001). Besides its capability of creating life-endangering 
infections, this human pathogen has also shown an exceptional potential to develop 
an antimicrobial resistance. 
 
2.1.2 Prevalence of S. aureus resistance 
The European Centre for Disease Prevention and Control carried out a 
research in 2009 and reported that in Europe Member States hospitals, approximately 
380,000 healthcare associated infections annually are caused by bacteria that are 
resistant to antibiotics. Chambers and colleagues (2001) study showed that in most 
Asian countries, relatively 70-95% of S. aureus strains were reported to be 
methicillin and penicillin-resistant. Apart from that, 75% of morbidity post-injuries is 
also reported to be related to infections (Church et al., 2006), that is commonly 
caused by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus 
(MRSA) (Vindenes & Bjerknes, 1995). Saba et al. (2017) study showed that the 
isolates of S. aureus and MRSA had high rates of resistance to the antibiotics used in 
Ghana. 
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2.2 Methicillin resistant Staphylococcus aureus (MRSA) 
After introducing β-lactamase-insensitive Penicillin into medical settings, 
MRSA strains were first notably spotted in hospitals, where they remain to be a 
severe risk in health care. This is caused by their capability to amass multidrug 
resistance determinants. Besides MRSA, Methicillin-sensitive S. aureus (MSSA) is 
also capable of causing outbreaks of diseases in a hospital (Kurlenda et al., 2009), 
but it is the infections that are caused by MRSA which are spread throughout the 
hospitals with ease. Therefore, without proper establishment of surveillance program 
with controlled method and techniques, a high risk of an epidemic in such hospitals 
is inevitable (Kurlenda et al., 2007). MRSA at molecular level is characterized by the 
existence of staphylococcal cassette chromosome, mec (SCCmec), a large mobile 
genetic element. It bears the mecA gene which codes PBP2a, a penicillin binding 
protein alternate that has a low attachment affinity to all β-lactams (Ito et al., 1999). 
Globally, MRSA has become a crucial cause of nosocomial infections and is 
currently the most commonly known antibiotic-resistant pathogen in the hospitals of 
United States (Monaco et al., 2016). 
 
2.2.1 Strategies to Fight MRSA  
There are a couple of healing strategies introduced in which some are still 
under progress, to fight MRSA such as therapeutic vaccines, antibiotic-free 
treatments, antibiotic-based treatments, alternative treatment, and immunotherapy. 
(McKenna, 2012: Zhao et al., 2015 and Bal et al., 2005). Among these treatments, 
antibiotics usage has been proven to be effective and most important historically. 
Unfortunately in recent decades, an alarming trend has been observed in which there 
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is an upsurge of antibiotic resistance but a decline in antibiotic study and 
development (Boucher et al., 2009 and Spellberg et al., 2004).  
Spellberg et al. (2004) reported that since 1968 only two novel classes of 
systemic antibiotics, linezolid (2000) and daptomycin (2003) were developed due to 
the failure of garnering interest for the development of antibiotics. Some of the 
reasons contributing to this scenario are lack of commercial interests, short-term 
usage and low profit motivations (Arias, 2009). Besides that, the level of difficulty 
for conducting clinical trials against these drug-resistant strains is high and therefore 
diminishes the hope of many researchers for final approval (Boucher et al., 2009). 
However, an emerging trend is noticed when the efforts of the U.S. FDA (Food and 
Drug Administration) to restart the antibiotic development (Shlaes et al., 2013) has 
quicken the drug approvals and documented development of antibiotics.  
In the effort to look for an effective treatment for MRSA, some of the 
existing established drug had been extensively researched. Simvastatin that used 
predominantly for cardiovascular disease has been anticipated to exhibit 
antimicrobial activity against skin bacterial disease. It is found to exhibit wide range 
of antibacterial activity including a few MRSA stains, anti-staphylococcal biofilm 
potential, anti-inflammatory and wound healing activities (Thangamani et al., 2015). 
In addition, simvastatin was also found to have synergistic effect with antimicrobials. 
Apart from simvastatin, tamoxifen, is also broadly used for the treatment of breast 
cancer. Tamoxifen is a selective estrogen receptor modulator that has been relocated 
to boost MRSA clearance by enhancing the neutrophil bactericidal capacity 
(Thangamani et al., 2015). 
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2.2.2 Ethnomedical Remedies against MRSA 
Antibiotics are progressively being defeated in the battle against microbes 
globally. A widespread adversity can be observed in this ever evolving world. This 
dire need compel people to reconsider the “old-fashioned” but still in practise, 
ethnomedicine, which originates from rational, constructive, empirical and “almost 
forgotten” knowledge about natural products. The resources are mainly based on 
herbs in which many active compounds have been isolated. Nevertheless, many 
remedies and treatments are yet to be verified, and therefore more proofs are needed 
to substantiate their usage in modern treatments. Unfortunately, there is a passive 
transition of ethnomedicine to evidence-based medicine due to the non-fitting 
capability of natural product-centered paradigms in the ethnomedical research scope. 
The complexity form of the active compounds in these ethnomedicinal materials due 
to pleiotropic effects produces a wide but unclear spectrum of their ethnomedical 
indications. In addition to this, the prescribed recipes may have different formulas to 
enhance their healing effectiveness known as Bianzheng lunzhi in Chinese folk 
medicine, which directly means “pattern differentiation and treatment determination” 
(Temrangsee et al., 2011). The general populace in the developing world, continue to 
use healing agents that are naturally derived in context to historical context and 
theory of ethnomedicine procedures.  
Ethnomedical drugs may fight against drug-resistant strains through their anti-
biofilm activities. This is because, formation of biofilms confers antibiotic resistance 
to bacteria. For instance, one medicinal plant that has displayed inhibition towards 
MRSA is the plant Duabanga grandiflora. This plant is capable to inhibit the 
formation of biofilm in MRSA by reducing the cell surface attachment and the 
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attenuation of the level of PBP2a (Santiago et al., 2015). Encoded by mec A, PBP2a 
encourages the emergence of MRSA, due to it being a protein that presents β-lactam 
antibiotic resistance to S. aureus (Kreiswirth et al., 1993). In addition to that, 
naturally derived substances may encompass some inhibitors of multidrug efflux 
pumps (Bharate et al., 2015), which in turn are treated to detoxify antibiotics by 
multi- and pan-resistant S. aureus (Costa et al., 2013). Besides that, naturally derived 
substances are also used to reverse the effect of microbial antibiotic resistance and by 
doing so helps to limit the over usage of antibiotics. Nevertheless, whether these 
naturally derived materials have a low resistance capability by themselves remains 
vague.  
 
2.3 Mesua ferrea Linn. 
2.3.1 Botanic Description 
Mesua ferrea (Figure 2.1) is an average-sized tree with a height up to 36 m 
and a trunk that is 95 cm in diameter. The trunk is also usually cylindrical to poorly-
shaped. The bark surface is unwrinkled to sometimes scaly. It is has a brown colour 
with a bright orange layer below. The shiny leaves on the other hand are simple and 
opposite, normally elliptical and glabrous with plenty of secondary veins, curving 
parallel of the border. The flowers are axillary, solitary and bisexual. It has 4 sepals 
that are decussate, persistent and suborbicular. It has an up to 9-flowered open 
panicle and pedicel that has small paired bracts. Besides that, the flower is either 
pink or white with 4 petals, as shown in Figure 2.2. It has plenty of stamens, either 
free or united but only at the base. The fruit is normally globose and appears like a 
capsule, beaked, commonly seen as thin and woody, usually cleaving with 2(-4) 
valves before falling, that normally exudes resinous droplets. One fruit may have one 
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to four seeds (Dassanayake, 1980). The generic name for the plant is given after J. 
Mesue (777-857) and the specific descriptive name is originated from Latin which 
also means ‘belonging to iron’, notable to its famous hard, durable timber. It is 
generally known in Malaysia as Penaga Lilin. 
 
Figure 2.1: M. ferrea tree in Universiti Sains Malaysia. 
                     
Figure 2.2: Mesua ferrea Linn. – A. Small branch with a flower (x1); B. L.s through 
a flower showing floral parts (x2); C. Part of a filament with anther; D. T.s through 
ovary; E. A small fruit; F. Bursting fruit (x1/2) 
(Source:http://www.biologydiscussion.com/angiosperm/dicotyledonae/classification-
of-parietales-11-families-dicotyledonae/42464) 
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2.3.2 Biology and Ecology 
M. ferrea blossoms during the dry season and flushes of new leaves that are 
usually formed right after the flowering at the start of the rainy season. The flowers 
of M. ferrea blooms for one day, where it opens at 3 or 4 a.m. and closes around 
sunset. M. ferrea is usually associated with dipterocarps in Borneo. In mountainous 
evergreen forest, it commonly observed as an understorey tree whereas in the 
lowland forest, it is usually seen as a canopy component. M. ferrea needs a rather 
rich, well-drained soil. 
 
 
2.3.3 Distribution  
The tree is commonly found at a height up to 1500 m elevation in tropical 
evergreen forests throughout Southeast Asia (Dassanayake, 1980). It is largely 
distributed in countries such as Myanmar, Malaysia, Thailand, India, New Guinea 
and Sri Lanka (Kritikar and Basu, 1981). In the tropical India, the distribution of this 
plant is mainly observed in the montane range of Andaman, Assam, Eastern 
Himalaya and East Bengal (Anonymous, 2004) where it is also locally known with a 
different name. M. ferrea is called in English as Cobra’s saffron, in Hindi as 
Nagakeshara, in Tamil as Nagachampakam, in Assam as Nageshwar and in Kannada 
as Nagasampige. 
 
2.3.4 Uses  
M. ferrea is acknowledged for improving human thermal relief by its shade 
production and radiation modification. The seed oil has also been proven to be a 
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good alternative for petroleum gasoline, where a distillation of the fraction between 
200 and 300°C can produce fuel for diesel engines (Konwer et al., 1984; Kallappa et 
al., 2003). Besides that, the seed oil can also produce polymers that are used to 
prepare resins (Dutta et al., 2005; Mahapatra et al., 2004; Das et al., 2010).  
Konwarh et al. (2010) has reported that the aqueous leaf extract was used in 
the preparation of silver Nano particles whereas Sahni (1998) investigated that the 
seeds are brunt like candles, the stamens and flowers are normally used to stuff 
pillows for the bridles bed, while the wood is commonly used for the heads of golf 
clubs.   
 
2.3.5 Ethno pharmacological relevance of Mesua ferrea Linn 
Numerous parts of the M. ferrea plant have tremendous values in the Indian 
folk medicine for the remedy of a variety of ailments. Parts of the trees such as the 
flowers and leaves are used to cure scorpion strings and snake bites.  Besides being 
used as astringents, the barks are also commonly used as a sudorific when in 
combination with ginger. The flowers as well are used as astringents besides being 
stomachic and expectorant, whereas the unripe fruits are sudofiric. The seed oil is 
externally used to cure cutaneous affections while the flower buds are commonly 
used in dysentery (Satyavati et al., 1987).  Apart from this, several varying aerial 
parts of M. ferrea are traditionally used in the folk medicines to prepare unguents and 
cosmetics. The kernels of the seeds are pounded and externally applied to poultice 
cuts and all designs of skin inflammations. 
Rai et al. (2000) observed that the plant is capable to treat septic and 
inflammation conditions whereas Parukutty et al. (1984) reports that the tribal of 
Assam uses this plant widely for its medicinal properties such as purgative, 
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antiseptic, worm controller, blood purifier and tonic properties. Apart from that, M. 
ferrea is also used to cure cold, asthma and fever in Thai folk medicine. (Foundation 
of Resuscitate and Encourage Thai Traditional Medicine, 2005). The ashes of M. 
ferrea leaves are used to treat sore eyes. (Kumar et al., 2006). M. ferrea is also an 
important component in many formulations of Ayurvedic practice that are used to 
treat various ailments (Roshy et al., 2010) such as in various “churnas” 
(Sharangadhara, 2000), mahakaleshwara rasa (Das et al., 2001) and dasamoolarishta 
(Nishteshwar et al., 2008). Not only that, there is also another formulation of 
Ayurvedic practice that incorporates M. ferrea where the recipe displayed 
haemostatic and astringent characteristics and therefore is notably helpful in the 
bleeding of uterus (Joy et al., 1992). In Unani folk medicine, it is a component of a 
wide amount of formulations such as, “Halwa-i-supari pack” a general tonic, “Hab 
Pachaluna”, an appetiser and “Jawarish Shehryaran” a stomach and liver herbal 
medicine (Joy et al., 1992). 
 
2.3.6 Pharmacological Activities 
2.3.6 (a) Disinfection studies 
M. ferrea seed kernel oil was investigated by Adewale et al. (2011) to have 
an impressive disinfection capability and the studies of disinfection kinetics pointed 
out that the seed kernel oil fits the first-order model with a k value of -0.040.  
 
2.3.6 (b) Antioxidant and hepatoprotective activity  
The flowers of M. ferrea were dried and the methanolic extract of the flowers 
(100 and 200 mg/kg) was investigated in female Wistar rats for hepatoprotective and 
in vivo antioxidant activity. The study showed a notable increase in liver for super 
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oxide dismutase (SOD) and aspartate aminotransferase (AST) in treated groups. 
Apart from this, there was a sharp decline in catalase (CAT), glutathione peroxidise 
(GPX), glutathione reductase (GR) and alanine aminotransferase (ALT) activity and 
there was no substantial difference that was noticed in Creatinine and Creatinine 
phosphorkinase (CPK) activity (Garg et al., 2009).  
Makchuchit et al. (2010) investigated the ethanolic extract of M. ferrea 
flowers and observed an activity of strong inhibition (96.03%) against nitric oxide 
(NO) assay at 100 μg/ml whereas Yadav (2010) reported that the ethanol-water (1:1) 
leaf extract of M. ferrea exhibited strong inhibition on peroxidation of lipid. The 
natural food supplement Maharishi AK-4 (Cullen et al., 1997)  and Brahma rasayana 
(Ramnath et al., 2009) (refer to Appendix Table 7.1) which is formulated in 
Ayurveda consisting M. ferrea as a potent ingredient have been recorded to display 
notable antioxidant activity in isolated rat and cold stressed chicken heart 
respectively. 
 
2.3.6 (c) Analgesic activity  
Hassan et al. (2006) studied the analgesic activity of the M. ferrea leaves 
extracts from methanol, ethyl acetate and n-Hexane (125 and 250 mg/kg). Each 
extract displayed a potent analgesic activity in acetic acid induced writhing response 
in mouse. The declination in writhing feedback for for higher dosage of above 
extracts was 17.06, 19.63, and 42.21%, respectively whereas the lower dosage was 
10.21, 16.33 and 36.08%, respectively.  
 
2.3.6 (d) Antispasmodic activity  
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The antispasmodic activity of M. ferrea seed oil petroleum extract was 
assessed in vitro by Prasad et al. (1999) on isolated rat ileum. Kymograph was used 
to evaluate the contraction of rat ileum. Carbachol and Acetycholine caused a 
contraction of 3.20 and 2.61 cm, respectively. A reduction of 55% was observed for 
the response of acetylcholine in the presence of atropine.  
 
2.3.6 (e) Anti-venom activity  
The aqueous extract of this plant’s leaves was investigated for its anti-venom 
activity against the viability of fibroblast cells. After treating the cells with 0.706 
mg/ml M. ferrea extracts that was pre-incubated with Heterometrus laoticus scorpion 
venom, the study showed that M. ferrea leaf’s aqueous extracts was efficient in 
protecting the fibroblast cells against the scorpion venom induced lysis. (Uawonggul 
et al., 2006). 
2.3.6 (f) Anti-ulcer activity  
Using pyloric ligation procedure in albino rats, the antiulcer activity for the 
xanthones from M. ferrea were evaluated. The animals that were pre-treated with 
xanthones displayed only dispersed sites of hyperemia and sporadic haemorrhagic 
spots while the control animals observed sustained extensive ulceration, perforation 
and haemorrhage.  A distinctive lower value (3.50 ± 0.27) of ulcer scoring for the 
gum acacia treated rats was noticed comparative to that of standards. 
(Gopalakrishnan et al., 1980). 
 
2.3.6 (g) Anti-microbial activity  
Mazumder et al. (2004) studied the methanolic extract of M. ferrea flowers in 
vivo and in vitro experiments. A declination of mice mortality was observed when 
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the methanolic extract of protected mice was stimulated with S. typhimurium ATCC 
6539.2 in the in vivo experiment. Apart from this, an obvious depletion of the viable 
bacteria of blood, spleen and liver was noticeable in the extract-treated mice. In the 
in-vitro experiment, the methanolic extract was also capable to inhibit at 50 μg/mL of 
concentration, all the approved strains of Pseudomonas spp., Salmonella spp., 
Bacilllus spp., Lactobacillus arabinosus Proteus mirabilis, Sarcina lutea, 
Streptococcus pneumonia and the 30 strains of Staphylococcus aureus in the in vitro 
experiment.  
Complete inhibition at 500 and 1000 μg/ml were shown against all tested 
bacteria by dichloromethane and methanol (1:1 v/v) extracts of M. ferrea flowers. 
The study was carried out by using the agar dilution-streak method against 14 
bacterial strains (Prashanth et al., 2006).  
Ali et al. (2004) reported that the M. ferrea leaves extracts of light petroleum 
ether, chloroform and ethanol were found to have mediocore activity against many of 
the tested bacteriums. The chloroform extract of M. ferrea stem bark was 
investigated and it showed significant strong activity against Gram-negative E. coli 
(19 mm) and Gram-positive S. aureus (16 mm) using disk diffusion method. All 
these M. ferrea extracts did not show much antifungal activity against the tested 
fungal strains.  
In another report by Parekh et al. (2007) where the alcoholic and aqueous 
extracts of M. ferrea seeds were evaluated for antibacterial activity using the agar 
disc diffusion and agar well diffusion techniques, the ethanolic or methanolic 
extracts had a better antibacterial activity compared to aqueous extracts. From this 
study, it is also observed that the extracts had the strongest antibacterial activity 
against K. pneumoniae (20 mm) and P. mirabilis (23 mm). 
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The flowers of M. ferrea also showed interesting activity against Gram 
positive Staphylococcus, Enterococcus, Gram negative bacteria, and a strain of S. 
durans, and fungi P. falciparum. 4-Alkyl and 4-phenyl coumarins that were isolated 
from this part of the plant displayed a high minimum inhibitory concentration (MIC) 
of 2 to 4 μg/ml against all strains except for P. falciparum where a weak response 
was noticed (Verotta et al., 2004).  
Methanolic and ethanolic extracts of M. ferrea leaves were investigated by 
Adewale et al. (2012) for their antibacterial activity by evaluating the minimum 
inhibition concentration (MIC) and minimum bactericidal concentration (MBC) of 
these extracts. Both methods showed an interesting result for these extracts where the 
MIC range and MBC value for the Gram-negative bacteria was reported to be 2.5 to 
0.625 mg/ml and 5 mg/ml, respectively whereas for the Gram-positive bacteria the 
result obtained showed that the MIC range was 1.3 to 0.313 mg/ml while the MBC 
value was 2.5 mg/ml.  
 
2.3.7 Phyto-constituents 
Interestingly, M. ferrea has been the only species from the genus Mesua to be 
widely investigated chemically (Rao et al., 1981) and there are many reports on the 
phytochemical research on this plant which has resulted on varying classes of 
secondary metabolites isolated from M. ferrea. These secondary metabolites 
comprising of xanthones, triterpenoids and phenylcoumarins (Raju et al., 1976). 
From the seed oil of M. ferrea, 4-Phenylcoumarins such as mesuol (1), mesuagin (2), 
mammeisin (3), mammeigin (4) and mesuone were isolated. Apart from this, an oil 
called Nahor was also separated from the kernel seeds. (Joy et al., 1998).   
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Compounds such as 4-alkylcoumarins ferruols A and B, mesuaxanthones A 
(5) and B (6) and 1, 7-dihydroxyxanthone were isolated out of the bark of the M. 
ferrea trunk whereas β-sitosterol, biflavonoids- mesuaferrones A (7) and B (8), α and 
β-amyrin, mesuaferrol, and mesuanic acid were isolated from the stamens of the 
plant which is responsible for yielding the drug Nagakeshara according to Ayurvedic 
texts. (Handa et al., 1992).Apart from this, other compounds that were isolated 
include euxanthone and leuco anthocyanidin (Sharma et al., 2002).  
 
Figure 2.3: Chemical structures of compounds isolated from M. ferrea. 
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2.4 Herbal mixtures versus isolated compounds 
For centuries products that are naturally derived from plants have played a 
dominant role in the field of medicine. The general populace has been dependant on 
herbal and folk medicines to cure diseases. However, in 1897 the discovery of 
aspirin, a drug synthetically obtained from salicylic acid, has changed the medical 
trend to mono-drug treatment. This approach of employing a singular synthetic drug 
or naturally derived single compound, to cure ailments shifted the paradigm in drug 
discovery (Williamson, 2001). This mono-drug therapeutic approach was further 
strengthened by the creation of high throughput screening (HTS) and structure 
activity-guided organic synthesis. Some of the many benefits of utilizing this 
approach is that the study on pharmacodynamics and pharmacokinetics properties, its 
side effects and mechanism of actions are made easier to comprehend. Some of the 
various early examples of these mono-drugs such as pilocarpine, penicillin, morphine 
and quinine were isolated mainly from natural products. For instance, morphine was 
derived from opium that was isolated from the poppy plant (Papaver somniferum) 
(Katiyar et al., 2012; Harvey, 2008). 
On the contrary, herbal preparations contains a mixture of different 
compounds. The mixture of ingredients for these preparations is either found in a 
single plant or a number of different plants. In most of the folk medicines practised, 
herbal treatment has become a daily basis of curing diseases. Comparative to mono-
drug treatment, herbal preparations are better because the multicomponent 
preparation is able to increase the medicinal properties of the treatment, such as 
increasing the bioavailability of the pharmacological activities of each component 
and reducing the toxicity of the preparations in whole (Schmidt et al., 2008). 
According to Cravotto et al. (2010) the effect of combining a few compounds 
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together or the potency of one whole plant itself has high healing activity. In most 
cases, the therapeutic effect is reduced with repeated fractionation and isolation as 
loss of key components that is active against other pharmacological activity (Raskin 
& Ripoll, 2004). This “synergism” between different components in a preparation is 
the main cause for the boost in the healing potential of herbal mixtures. With a sharp 
increase of pathogenic resistance and the variety of response towards a single 
treatment has made the large populace to revert back to herbal concoctions. It is also 
noteworthy to mention that many researchers are also looking back to this 
“synergistic” approach to enhance the pharmacological activity of a treatment. The 
usage of different isolated compounds or drugs in a combination to target different 
ailments in a whole are in fact the apparent benefit of herbal medicines.  
 
2.5 Separation techniques 
According to the chemical nature of the active compounds, there are several 
techniques to separate out active compounds from the plant extract. The technique of 
having the mobile phase and the stationary phase selectively collecting the 
compounds is the primary method used to isolate and separate the compounds.  
  Since many decades ago, thin layer chromatography (TLC) has become the 
most commonly used separation technique as it is famed for its quick separation 
techniques and cost effectivity. TLC is a crucial step to determine the perfect 
combinations of solvents that is needed to separate out the compounds from the 
extract or fraction for further isolation and purification. The stationary phase 
(adsorbents) for TLC such as silica or reverse phase silica is coated on a glass or 
aluminum plates. The original size that these TLC plates are commonly distributed 
are of 20 cm × 20 cm size but these plates are normally cut into smaller sizes to fit 
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the choice of users. In order to prepare for the mobile phase for the TLC technique, 
two or more solvents with different polarity are mixed to give a variety of eluting 
strength to different mobile phases. A spot of extract is usually developed at the 
origin limit of a TLC plate and then placed in a glass jar that has an atmosphere 
which is saturated with the eluting solvent. As different compounds have different 
polarity, they are attracted towards the different polarity of the eluting solvents. 
Separation of the extract on TLC happens along with the movement of the eluting 
solvent upwards that is caused by the capillary action. As a result, at the end of the 
elution of the mobile phase, a well separated image of the extract is observed on the 
TLC either with naked eye or by viewing the plate under ultraviolet (UV) 
illumination. Further chemical nature of the compounds can be attained by spraying 
the TLC plate with appropriate reagents (Gilbert & Martin, 1998).  
After many trial and errors, once the right separation has been obtained on a 
TLC plate, the same mobile phase is prepared for Preparative thin layer 
chromatography (Prep-TLC). Prep-TLC is a technique that is used at a larger scale 
but normally this technique is only preferred as the final step of isolation or 
purification. Like TLC, the separation on Prep-TLC is identified by UV rays or 
reaction with a specific reagent. Once the bands of different compounds are 
confirmed, the adsorbent of the specific bands are scraped out and later desorbed by 
a solvent that is able to dissolve the compound needed. 
Apart from this, another separation technique that has been proven to benefit 
the research in natural product vastly is the column chromatography. Column 
chromatography can be divided into two types, flash column and open column. Flash 
column functions by using external air pressure to elute compounds whereas open 
column performs by engaging gravitational force for elution of compounds. 
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Recently, flash column chromatography has been preferred to open column because 
of its capability to elute compounds in a shorter span of period. Not only that, the 
efficiency of flash column to give a better separation has made it replace the cost 
effective open column. Selection of certain parameters in column chromatography is 
important in order to isolate out compounds from an extract or fraction. Options such 
as diameter and length of the column, the size of sample load and the composition of 
mobile phase is crucial and is usually determined by analyzing the complex nature of 
the sample and its interaction with stationary phase (Bohen et al., 1973).  
Another alternative to open and flash chromatography is Dry Column 
Vacuum chromatography (DCVC). DCVC functions with lesser amount of silica and 
solvent compared to the other columns using techniques of gradient fractionation 
where after each step of solvent elution, the sorbent bed is dried out using a vacuum 
pump before the next solvent system is added. It is common to use this technique in 
separating crude mixtures that are complex into simpler fractions (Pedersen & 
Rosenbohm, 2001).  
Besides these chromatographic methods, other chromatographic techniques 
such as supercritical fluid chromatography, counter current chromatography and high 
performance liquid chromatography (HPLC) is also being commonly used to 
separate mixtures these days. Recently, these techniques have become very popular 
among researchers as they provide automated control over the separation of 
compounds besides being specific to its separation (Coskun et al., 2016).  
 
 
 
 
